Novel germline p16 mutation in familial malignant melanoma in southern Sweden

Cancer Research

Volumn 56, Issue 11, 1996, Pages 2497-2500

  Borg, Åke ^a   Johansson, Ulla ^a   Johannsson, Oskar ^a   Håkansson, Sara ^a   Westerdahl, Johan ^a   Måsbäck, Anna ^a   Olsson, Håkan ^a   Ingvar, Christian ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANKYRIN; ARGININE; CYCLIN DEPENDENT KINASE; MICROSATELLITE DNA; NUCLEOTIDE; ONCOPROTEIN;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER SUSCEPTIBILITY; CELL CYCLE G1 PHASE; CHROMOSOME 9P; CHROMOSOME MARKER; CHROMOSOME SATELLITE; CLINICAL ARTICLE; FAMILIAL CANCER; FEMALE; GERM LINE; HAPLOTYPE; HETEROZYGOTE; HUMAN; HUMAN TISSUE; MALE; MELANOMA; MUTATION; NONHODGKIN LYMPHOMA; PANCREAS CARCINOMA; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; SWEDEN; UTERINE CERVIX CARCINOMA;

CARRIER PROTEINS; CHROMOSOMES, HUMAN, PAIR 9; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; GENES; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MELANOMA; PEDIGREE; POINT MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SWEDEN;

EID: 0029891364     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Skolnick, M H., Cannon-Albright, L A. and Kamb, A. Genetic predisposition to melanoma Eur J. Cancer. 30A: 1991-1995, 1994
2. Cannon-Albright, L. A , Goldgar, D E , Meyer, L J , Lewis, C. M., Anderson, D. E , Fountain, J W., Hegi, M. E., Wiseman, R. W , Petty, E M., Bale, A. E., Olopade, O I., Diaz, M O , Kwiatkowski, D. J., Piepkorn, M W , Zone, J J , and Skolnick, M. H. Assignment of a locus for familial melanoma. MLM, to chromosome 9p13-p22. Science (Washington DC). 258: 1148-1152, 1992.
3. Goldstein, A. M., Dracopoli, N. C., Engelstein, M , Fraser, M. C., Clark, W H., and Tucker, M. A Linkage of cutaneous malignant melanoma/dysplastic nevi to chromosome 9p, and evidence for genetic heterogeneity Am J Hum. Genet. 54: 489-496, 1993
4. Nancarrow, D. J., Palmer, J. M , Walters, N. K., Kerr, G J., Hafner, L , Garske, R., McLeod, R , and Hayward, N K. Confirmation of chromosome 9p linkage in familial melanoma Am. J Hum Genet. 53: 936-942, 1993
5. Bale, S. J. Dracopoli, N C., Tucker, M. A., Clark, W H , Fraser, M. C , Stanger, B Z., Green, P , Donis-Keller, H , Housman, D. E , and Greene, M H. Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome Ip N. Engl. J. Med., 320: 1367-1372, 1989.
6. Serrano, M , Hannon, G. J., and Beach, D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond.), 366: 704-707, 1993.
7. Kamb, A., Gruis, N. A., Weaver-Feldhaus, J , Liu, Q , Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., III, Johnson, B E., and Skolnick, M. H. A cell cycle regulator potentially involved in genesis of many tumor types Science (Washington DC), 264: 436-440, 1994.
8. Serrano, M., Gomez-Lahoz, E., DePinho, R A., Beach, D., and Bar-Sagi, D Inhibition of ras-induced proliferation and cellular transformation by p16-INK4 Science (Washington DC), 267: 249-252, 1995
9. Caldas, C., Hahn, S. A , da Costa, L. T , Redston, M. S , Schutte, M . Seymour, A. B., Weinstein, C. L., Hruban, R H , Yeo, C. J , and Kern, S. E. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat. Genet, 8: 27-32, 1994
10. Mori, T , Miura, K., Aoki, T., Nishihira, T , Mori, S., and Nakamura, Y. Frequent somatic mutation of the MTS1/CDK41 (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res , 54: 3396-3397, 1994.
11. Cairns, P , Mao, L. Merio, A., Lee, D. J., Schwab, D., Eby, Y., Tokino, K., van der Riet, P., Blaugrund, J. E., and Sidransky, D. Rates of p16 (MTS1) mutations in primary tumors with 9p21 loss. Science (Washington DC), 265: 415-416, 1994.
12. Merlo, A., Herman, J. G., Mao, L., Lee, D J , Gabrielson, E., Burger, P. C., Baylin, S. B., and Sidransky, D. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2.MTS1 in human cancers Nat. Med , 1: 686-692, 1995.
13. Little, M., and Wainwright, B. Methylation and p16, suppressing the suppressor. Nat. Med., 1: 633-634, 1995.
14. Hussussian, C. J., Struewing, J. P., Goldstein, A. M , Higgins, P A. T , Ally, D. S , Sheahan, M. D , Clark, W. H , Jr., Tucker, M A , and Dracopoli, N C. Germline p16 mutations in familial melanoma. Nat. Genet. 8: 15-21, 1994.
15. Kamb, A , Shattuck-Eidens, D., Eeles, R., Liu, Q., Gruis, N. A , Ding, W., Hussey, C., Tran, T., Miki, Y., Weaver-Feldhaus, J., McClure, M., Aitken, J F., Anderson, D. E , Bergman, W., Frants, R., Goldgar, D. E., Green, A . MacLennan, R , Martin, N. G , Meyer, L. J., Youl, P , Zone, J J , Skolnick, M H., and Cannon-Albright, L. A. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet. 8: 22-26, 1994
16. Walker, G. J , Hussussian, C J, Flores, J F, Glendening, J M., Haluska, F. G., Dracopoli, N. C., Hayward, N. K., and Fountain, J. W. Mutations of the CDKN2/pI6INK4 gene in Australian melanoma kindreds. Hum Mol Genet, 4: 1845-1852, 1995.
17. Gruis, N. A , van der Velden, P A., Sandkuijl, L A., Prins, D. E., Weaver-Feldhaus, J. Kamb, A., Bergman, W., and Frants, R. R. Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds Nat. Genet., 10: 3511-353, 1995.
18. Johannsson, O., Ostermeyer, E. A., Håkansson, S , Friedman, L. S., Johansson, U , Sellberg, G., Brøndum-Nielsen, K , Sele, V., Olsson, H. King, M-C., and Borg, Å. Founding BRCA1 mutations in hereditary breast/ovarian cancer from South Sweden. Am. J. Hum. Genet, 58: 441-450, 1996.
19. Cairns, P., Polascik, T. J., Eby, Y., Tokino, K., Califano, J., Merlo, A., Mao, L., Heraih, J., Jenkins, R , Westra W., Rutter, J. L , Buckler, A , Gabrielson. E., Tockman, M., Cho, K. R., Hedrick, L., Bova, G. S., Isaacs, W., Koch, W., Schwab, D , and Sidransky, D. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours Nat Genet., 11: 210-212, 1995.
20. Sherr, C. J , and Roberts., I M Inhibitors of mammalian G1 cyclin-dependent kinases. Genes & Dev., 9: 1149-1163, 1995.
21. Yang, R., Gombart, A. F., Serrano, M , and Koeffler, H. P Mutational effects on the p16-INK4a tumor suppressor protein. Cancer Res., 55: 2503-2506, 1995.
22. Ranade, K., Hussussian, C. J., Sikorski, R. S., Varmus, H. E., Goldstein, A. M., Tucker, M. A., Serrano, M., Hannon, G. J., Beach, D , and Dracopoli, N. C. Mutations associated with familial melanoma impair p16-INK4 function. Nat. Genet, 10: 114-116, 1995.
23. Lukes, J., Parry, D., Aagaard, L., Mann, D. J., Bartkova, J., Strauss, M., Peters, G., and Bartek, J. Retinoblastoma protein-dependent cell-cycle inhibition by the tumour suppressor p16 Nature (Lond.), 375: 503-506, 1995.
24. Wolfel, T., Hauer, M. Schneider, J , Serrano, M., Wölfel, C., Klehmann-Hieb, E , De Plaen, E., Hankeln, T. Meyer zum Buschenfelde, K-H., and Beach, D. A 16-INK4a insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma Science (Washington DC), 269: 1281-1284, 1995
25. Zou, L., Weger, J., Yang, Q., Goldstein, A M., Tucker, M. A., Walker, G. J., Hayward, N., and Dracopoli, N. C. Germline mutations in the p16-INK4a binding domain of CDK4 in familial melanoma Nat. Genet., 12; 97-99, 1996.
26. Cannon-Albright, L. A., Meyer, L. J., Goldgar, D. E., Lewis, C. M., McWhorter, W. P., Jost, M., Harrison, D., Anderson, D. E., Zone, J. J., and Skolnick, M. H. Penetrance and expressivity of the chromosome 9p melanoma susceptibility locus (MLM). Cancer Res., 54: 6041-6044, 1994
27. Bergman, W , Watson, P., de Jong, J , Lynch, H. T., and Fusaro, R. M. Systemic cancer and the FAMMM syndrome. Br. J. Cancer, 61: 932-936, 1990.
28. Goldstein, A M , Fraser, M. C., Struewing, J. P , Hussussian, C. J., Ranade, K., Zametkin, D P., Fontaine, L. S., Organic, S M., Dracopoli, N. C., Clark, W. H , Jr., and Tucker, M. A. Increased risk of pancreatic cancer in melanoma-prone kindreds with p161NK4 mutations. N Engl. J. Med., 333: 970-974, 1995.
29. Whelan, A. J., Bartsch, D , and Goodfellow, P. J. A familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor suppressor gene. N. Engl. J. Med., 333: 975-977, 1995.
30. Otterson, G. A , Kratzke, R. A., Coxon, A., Kim, Y. W., and Kaye, F. J. Absence of p16(INK4) protein is restricted to the subset of lung cancer cell lines that retains wildtype RB Oncogene, 9: 3375-3378, 1994.
31. Jen, J , Harper, J. W., Bigner, S H., Bigner, D. D., Papadopoulos, N., Markowitz, S., Willson, J. K. V., Kinzler, K. W., and Vogelstein, B. Deletion of p16 and p15 genes in brain tumors. Cancer Res, 54: 6353-6358, 1994.
32. Haidar, M. A., Cao, X. B., Manshouri, T., Chan, L L., Glassman, A., Kantarjian, H. M., Keating, M. J., Beran, M. S., and Albitar, M. P16(1NK4A) and p15(INK4B) gene deletions in primary leukemias. Blood, 86: 311-315, 1995.